Stayble Therapeutics A groundbreaking treatment of chronicle low back pain
| Reference number | |
| Coordinator | Encubator AB - Encubator AB, Göteborg |
| Funding from Vinnova | SEK 2 000 000 |
| Project duration | August 2014 - April 2016 |
| Status | Completed |
Purpose and goal
The VinnVerifiering main goal was to establish an organisation with key competences necessary to develop Stayble towards clinical trials. The project has given Stayble the possibility to verify the treatment concept both in vitro and in vivo and to attract and engage important collaboration partners.
Expected results and effects
The result of the VinnVerifiering project is that Stayble has performed the following goals with great result: 1) Clearly verified the benefit of an introduction of Stayble´s treatment 2) Verified the technical effect both in vivo and in vitro 3) Developed the project to a stage where continued financing through venture capital is possible
Planned approach and implementation
The VinnVerifierings project consisted of three main milestones: - MS-1 Commercial verification, manufacturing partners and regulatory strategy - MS-2 Verification of support systems, toxicological requirements and stability - MS-3 Preparation for clinical studies and further funding The milestones have been executed together with regulatory, clinical and toxicological experts in collaboration with Stayble´s internal organisation.